Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC2-01 Cream vs Vehicle and Active Comparator in Mild-to-Moderate Psoriasis Vulgaris
2018-001970-66Phase 3Completed
- Sponsor
- MC2 Therapeutics
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of calcipotriol + betamethasone in plaque psoriasis (3 arms), sponsored by MC2 Therapeutics. Primary endpoint: Percentage change from baseline in mPASI on the body at Week 8. Started Nov 2018; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2018-001970-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001970-66.